Hem › Atopisk dermatit (eksem) › Michigan
Kliniska studier för Atopisk dermatit (eksem) i Michigan
14 studier för Atopisk dermatit (eksem) söker deltagare vid platser i Michigan.
Städer i Michigan
Officiell studietext (engelska)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017, Ann Arbor
- Oakland Hills Dermatology- Site Number : 8400042, Auburn Hills
- Great Lakes Research Group - Bay City- Site Number : 8400052, Bay City
- och 3 fler
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Troy
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Auburn Hills
- Enveda Investigative Site, Bay City
- Enveda Investigative Site, Clinton Township
- och 1 fler
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Detroit
- Investigational Site, Troy
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07003425Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Derm Research Institute, PLC, Caledonia
RekryterarObservationsstudie
Ålder 12 till 89 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07645820A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Revival Research Institute, LLC, Troy
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07223697FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Revival Research Institute, LLC, Troy
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 70 · Alla kön · Uppdaterad 22 juli 2026 · NCT06564389A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Waterford
RekryterarFas 3
6 Months – 11 Years · Alla kön · Uppdaterad 7 juli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Henry Ford Medical Center - New Center One /ID# 263522, Detroit
RekryterarFas 3
Ålder 18 till 63 · Alla kön · Uppdaterad 6 juli 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Michigan Center for Research Company, Clarkston
- MI Skin Innovations, Northville
- Revival Research Institute LLC, Troy
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7066, Auburn Hills
- Galderma Investigational Site 7071, Caledonia
- Galderma Investigational Site 7108, Grandville
- och 1 fler
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT06988605Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
- University of Michigan, Ann Arbor
RekryterarFriska volontärer välkomna
Ålder 10 till 55 · Alla kön · Uppdaterad 25 nov. 2025 · NCT06300697Ethnic Differences in Mechanisms of Action of Dupilumab
- University of Michigan, Ann Arbor
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 6 nov. 2025 · NCT05268107A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 24 jan. 2025 · NCT06524635Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.